glp-1 receptor agonists should be avoided in patients with Dietary intake by taking and dual GIP/GLP-1 agonists: A narrative review and discussion of research needs Frontiers | Exploring the multifaceted

Carbohydrate12 g/0.48 g, of which sugars 0 g/0 g, of which polyols 9 g/0.36 g);Protein 0 g/0 g

BENEFITS Dual-pathway design GHRH-receptor and GHS-R engagement in a single formulation Convenience eliminates the need to source and reconstitute two separate vials Fixed 2:1 ratio consistent, reproducible co-administration across runs Complementary mechanisms the two classes are studied for additive rather than overlapping effects Verified identity both components MS-confirmed against a Janoshik report WHAT RESEARCHERS LOOK AT Synergistic vs additive effects of GHRH and GHS-R co-administration Comparative signalling: blend vs each compound administered alone Optimal GHRH:GHS-R ratios in combined formulations Pulsatility profiles from dual-receptor engagement Stability of a two-component lyophilized blend over storage QUICK SPECS Form: Lyophilized peptide blend Net per vial: 18 mg total (Tesamorelin 12mg + Ipamorelin 6mg) Purity: 99% (HPLC verified) Identity: MS-verified (per COA) Storage: 28C, protect from light and moisture Reconstitution: Use bacteriostatic water (sold separately) IDENTITY BASICS Components: Tesamorelin (CAS 218949-48-5) + Ipamorelin (CAS 170851-70-4) Blend ratio: 2:1 (12mg Tesamorelin : 6mg Ipamorelin) Classes: GHRH(1-44) analog + selective GHS-R (ghrelin receptor) agonist Ipamorelin sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2 (pentapeptide) WHY CHOOSE DURHAM PEPTIDES FOR THE TESAMORELIN + IPAMORELIN BLEND

Fragrance-free and suitable for all skin types Cleanses Exfoliates Brightens skin Benefits Deep Cleansing Action Effectively removes impurities with a thorough deep cleansing effect

How Joint Pain Affects Daily Life Reduced Mobility: Pain and stiffness can make everyday tasks more challenging

How a Collagen Supplement Works for the Skin Taking a collagen supplement regularly helps replenish declining collagen levels in the body

Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine